Contact
Please use this form to send email to PR contact of this press release:
Anoro® (umeclidinium/vilanterol) gains marketing authorisation in Europe for the treatment of COPD
TO:
Please use this form to send email to PR contact of this press release:
Anoro® (umeclidinium/vilanterol) gains marketing authorisation in Europe for the treatment of COPD
TO: